⌘K
Loading ticker…
As of 2026-08-24, Bicycle Therapeutics plc American Depositary Shares (BCYC) has a 3-month relative strength percentile of 38 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 42. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.6%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
BCYC is held by 4 ETFs as of May 2026. Top owner: SBIO at 0.15% weight, $241K notional. Top 3 carry $316K.
Held by 8 ETFs · $2M across latest filings · largest weight 0.47% (BBC).
Top 4 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SBIO | 0.15% | $241K | −0.04 pp |
| QQQS | 0.33% | $63K | −0.03 pp |
| IBBQ | 0.02% | $11K | — |
| BIB | 0.01% | $8K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BCYC Jan avg: -5.96% median: -5.52% win: 0% σ: 2.62% n: 4 2022-04-12 → 2026-07-31 | BCYC Feb avg: -0.69% median: -14.23% win: 25% σ: 29.84% n: 4 2022-04-12 → 2026-07-31 | BCYC Mar avg: -12.20% median: -12.72% win: 0% σ: 10.31% n: 4 2022-04-12 → 2026-07-31 | BCYC Apr avg: -5.78% median: -5.82% win: 40% σ: 8.12% n: 5 2022-04-12 → 2026-07-31 | BCYC May avg: -4.11% median: -3.97% win: 20% σ: 18.94% n: 5 2022-04-12 → 2026-07-31 | BCYC Jun avg: -4.49% median: -8.79% win: 40% σ: 9.65% n: 5 2022-04-12 → 2026-07-31 | BCYC Jul avg: 14.11% median: 20.11% win: 60% σ: 20.28% n: 5 2022-04-12 → 2026-07-31 | BCYC Aug avg: -6.08% median: -11.59% win: 25% σ: 12.26% n: 4 2022-04-12 → 2026-07-31 (current) | BCYC Sep avg: -2.38% median: -1.36% win: 50% σ: 8.79% n: 4 2022-04-12 → 2026-07-31 | BCYC Oct avg: -2.70% median: 3.93% win: 75% σ: 14.97% n: 4 2022-04-12 → 2026-07-31 | BCYC Nov avg: -1.90% median: -5.82% win: 25% σ: 13.11% n: 4 2022-04-12 → 2026-07-31 | BCYC Dec avg: -2.24% median: -1.57% win: 50% σ: 23.46% n: 4 2022-04-12 → 2026-07-31 |